Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial

Comment

M E Brecher et al. Transfusion. 2000 Mar.

. 2000 Mar;40(3):383-4.

doi: 10.1046/j.1537-2995.2000.40030383.x.

No abstract available

Comment on

Mathematical modeling of platelet survival with implications for optimal transfusion practice in the chronically platelet transfusion-dependent patient.
Hersh JK, Hom EG, Brecher ME. Hersh JK, et al. Transfusion. 1998 Jul;38(7):637-44. doi: 10.1046/j.1537-2995.1998.38798346631.x. Transfusion. 1998. PMID: 9683101
Optimal platelet dosing.
Brecher ME, Hom EG, Hersh JK. Brecher ME, et al. Transfusion. 1999 Apr;39(4):431-4. doi: 10.1046/j.1537-2995.1999.39499235680.x. Transfusion. 1999. PMID: 10220274 No abstract available.
Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial.
Klumpp TR, Herman JH, Gaughan JP, Russo RR, Christman RA, Goldberg SL, Ackerman SJ, Bleecker GC, Mangan KF. Klumpp TR, et al. Transfusion. 1999 Jul;39(7):674-81. doi: 10.1046/j.1537-2995.1999.39070674.x. Transfusion. 1999. PMID: 10413273 Clinical Trial.